Dr. Ali Tugrul Akin | Thymoquinone| Best Researcher Award

Dr. Ali Tugrul Akin , King’s College London , United Kingdom.

Dr. Ali Tugrul Akin is a dedicated Research Associate at King’s College London, specializing in Chronic Lymphocytic Leukemia (CLL). With a strong background in molecular and tissue biology, his expertise spans advanced laboratory techniques, including cell culture, transfection, qPCR, and flow cytometry. His meticulous approach to research, coupled with statistical analysis proficiency, has significantly contributed to understanding CLL. Holding a Ph.D. in Histology & Embryology from Erciyes University, he has cultivated leadership, supervision, and teamwork skills, fostering excellence in scientific inquiry. Passionate about innovation, Dr. Akin continues to drive impactful research in leukemia and cancer biology. 🏆🧪

Publication Profile

Orcid

Google Scholar

Education & Experience 🎓🔍

📌 Education:

• 🏛️ Ph.D. in Histology & Embryology – Erciyes University (2016–2021)
• 🧪 M.Sc. in Zoology – Erciyes University (2012–2016)
• 🔬 B.Sc. in Biology – Erciyes University (2008–2012)

📌 Experience:

• 🏥 Research Associate – King’s College London (Current)
• 🧫 Expert in Leukemia Research – Specialized in CLL, molecular biology, and histopathology
• 📊 Advanced Laboratory Techniques – qPCR, Western blotting, flow cytometry, ELISA, and more
• 🧠 Leadership & Supervision – Mentoring and guiding research teams

Suitability Summary

Dr. Ali Tugrul Akin, a distinguished Researcher Associate at King’s College London, is recognized with the Best Researcher Award for his groundbreaking contributions to Chronic Lymphocytic Leukemia (CLL), molecular biology, and histology. His extensive expertise in advanced laboratory techniques, including cell culture, transfection, qPCR, Western blotting, and histopathological evaluations, has significantly advanced the understanding of CLL at both molecular and clinical levels.

Professional Development 🚀📚

Dr. Ali Tugrul Akin has actively pursued continuous professional development in leukemia research and molecular biology. His expertise in histology, immunology, and bioinformatics has been enriched through hands-on experience with cutting-edge techniques like transfection, tissue processing, and qPCR analysis. He has developed a strong foundation in statistical data interpretation using tools like Prism and ImageJ. Additionally, his leadership and teamwork abilities have been sharpened through research collaborations, enabling him to foster a productive scientific environment. With a passion for discovery, Dr. Akin remains committed to advancing cancer biology and contributing to groundbreaking leukemia research. 🔬📈

Research Focus 🔍🧪

Dr. Ali Tugrul Akin’s research centers on Chronic Lymphocytic Leukemia (CLL), emphasizing molecular mechanisms, immunology, and targeted therapy development. His work involves in-depth investigations into leukemia cell behavior, transduction of c-kit cells, and advanced histopathological evaluations. He specializes in molecular biology techniques such as qPCR, nucleic acid extraction, and ELISA assays to explore cancer progression. His studies in histology and immunology contribute to understanding CLL at both the cellular and tissue levels, aiming to improve diagnostic and therapeutic strategies. Through his research, he seeks to bridge molecular insights with clinical applications, enhancing leukemia treatment approaches. 🧬🔬📊

Awards & Honors 🏆🎖️

🏅 Best Researcher Award – Recognized for significant contributions to CLL research
🏅 Outstanding Young Scientist Award – For excellence in molecular biology studies
🏅 Research Excellence Fellowship – Awarded for impactful research in histology and embryology
🏅 Scholarship from Erciyes University – Funding for Ph.D. research in histopathology
🏅 Best Poster Presentation Award – Recognized for innovative findings in molecular biology
🏅 King’s College London Research Grant – Funding support for advanced leukemia research

Publication Top Notes

1️⃣ Thymoquinone attenuates doxorubicin-induced cardiotoxicity
📄 Title: thymoquinone has a neuroprotective effect against inflammation, oxidative stress, and endoplasmic reticulum stress
👥 Authors: AT Akin, E Öztürk, E Kaymak, D Karabulut, B Yakan
📌 Journal: Anatomia, Histologia, Embryologia, Vol. 50 (6), Pages 908-917 (2021)
🔗 Focus: Investigates the neuroprotective effects ofthymoquinone in countering inflammation, oxidative stress, and endoplasmic reticulum stress. 🧠⚕️

2️⃣ Thymoquinone in Cardiotoxicity Protection
📄 Title: Thymoquinone attenuates doxorubicin-induced cardiac toxicity via antioxidant and anti-inflammatory mechanisms
👥 Authors: D Karabulut, E Ozturk, E Kaymak, AT Akin, B Yakan
📜 Journal: Journal of Biochemical and Molecular Toxicology 35 (1), e226 (2021)
🔗 Focus: Examines the cardioprotective role of thymoquinone in reducing oxidative stress and inflammation caused by doxorubicin.

3️⃣ Thymoquinone & Doxorubicin-Induced Hepatotoxicity
📄 Title: Thymoquinone has a protective effect against doxorubicin-induced hepatotoxicity via modulation of apoptosis and oxidative stress
👥 Authors: AT Akin, E Öztürk, E Kaymak, D Karabulut, B Yakan
📍 Published in: Anatomia, Histologia, Embryologia 50 (6), 908-917 (2021)
🧐 Key Focus: Investigates the anti-inflammatory, antioxidant, and anti-apoptotic effects of thymoquinone on doxorubicin-induced liver toxicity.

4️⃣ Thymoquinone in Leukemia Treatment
📄 Title: Thymoquinone’s Protective Role Against Doxorubicin-Induced Oxidative Stress and Apoptosis in Leukemia Cells
👥 Authors: AT Akin, E Öztürk, D Karabulut, B Yakan, HM Ünsal
🔍 Focus: Studies the protective effects of thymoquinone against doxorubicin-induced apoptosis in leukemia cells, exploring its potential therapeutic role in hematological malignancies.